Previous Chapter: B1. 1993: RU 486--A Decade on Today and Tomorrow
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 120
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 121
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 122
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 123
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 124
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 125
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 126
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 127
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 128
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 129
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 130
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 131
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 132
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 133
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 134
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 135
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 136
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 137
Suggested Citation: "B2. Overview and Background: Mechanism of Action of Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 138
Next Chapter: B3. The Use of Antiprogestins in the Reproductive Cycle
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.